Target and Its Patented Drug(s)

Content Navigation (  All   None )                                      
Target General Information
Patent(s) and the Corresponding Patented Drug(s)
References
Target General Information  Top
Target ID T90751 Target Info
Target Name N-acetylglucosaminyltransferase I (NAGAT1)
Synonyms N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I; MGAT; GlcNAc-T I; GNT-I; GLCT1; GGNT1; Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
Target Type Patented-recorded Target
Gene Name MGAT1
UniProt ID
MGAT1_HUMAN
Patent(s) and the Corresponding Patented Drug(s)  Top
United States Patent and Trademark Office (USPTO)
Patent ID US9656955
Title Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
Abstract The present invention relates to pyrrolidine derivatives of the formula (I), or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such pyrrolidine derivatives, and the use of such pyrrolidine derivatives for therapeutic purposes. The pyrrolidine derivatives are GlyT1 inhibitors.
Applicant(s) AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG
Representative Drug(s) D0V1PW Drug Info N.A. Click to Show More [1]
2 D01DYO Drug Info N.A. [1]
3 D0BJ3R Drug Info N.A. [1]
Patent ID US9656955
Title Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
Abstract The present invention relates to pyrrolidine derivatives of the formula (I), or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such pyrrolidine derivatives, and the use of such pyrrolidine derivatives for therapeutic purposes. The pyrrolidine derivatives are GlyT1 inhibitors.
Applicant(s) AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG
Representative Drug(s) D0V1PW Drug Info N.A. Click to Show More [1]
2 D01DYO Drug Info N.A. [1]
3 D0BJ3R Drug Info N.A. [1]
Patent ID US9656955
Title Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
Abstract The present invention relates to pyrrolidine derivatives of the formula (I), or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such pyrrolidine derivatives, and the use of such pyrrolidine derivatives for therapeutic purposes. The pyrrolidine derivatives are GlyT1 inhibitors.
Applicant(s) AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG
Representative Drug(s) D0V1PW Drug Info N.A. Click to Show More [1]
2 D01DYO Drug Info N.A. [1]
3 D0BJ3R Drug Info N.A. [1]
Patent ID US9586945
Title Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
Abstract The present invention relates to aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives of the formula (I) or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, and the use of such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives for therapeutic purposes. The aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives are GlyT1 inhibitors.
Applicant(s) AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
Representative Drug(s) D0Y6FF Drug Info N.A. Click to Show More [2]
2 D01OZO Drug Info N.A. [2]
3 D06WEY Drug Info N.A. [2]
Patent ID US9586945
Title Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
Abstract The present invention relates to aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives of the formula (I) or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, and the use of such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives for therapeutic purposes. The aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives are GlyT1 inhibitors.
Applicant(s) AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
Representative Drug(s) D0Y6FF Drug Info N.A. Click to Show More [2]
2 D01OZO Drug Info N.A. [2]
3 D06WEY Drug Info N.A. [2]
Patent ID US9586945
Title Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
Abstract The present invention relates to aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives of the formula (I) or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, and the use of such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives for therapeutic purposes. The aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives are GlyT1 inhibitors.
Applicant(s) AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
Representative Drug(s) D0Y6FF Drug Info N.A. Click to Show More [2]
2 D01OZO Drug Info N.A. [2]
3 D06WEY Drug Info N.A. [2]
Patent ID US9586942
Title Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
Abstract The present invention relates to aminotetraline and aminoindane derivatives of the formula (I) or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such aminotetraline and aminoindane derivatives, and the use of such aminotetraline and aminoindane derivatives for therapeutic purposes. The aminotetraline and aminoindane derivatives are GlyT1 inhibitors.
Applicant(s) AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
Representative Drug(s) D0NT3V Drug Info N.A. Click to Show More [3]
2 D0A0ND Drug Info N.A. [3]
3 D0L5AE Drug Info N.A. [3]
Patent ID US9586942
Title Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
Abstract The present invention relates to aminotetraline and aminoindane derivatives of the formula (I) or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such aminotetraline and aminoindane derivatives, and the use of such aminotetraline and aminoindane derivatives for therapeutic purposes. The aminotetraline and aminoindane derivatives are GlyT1 inhibitors.
Applicant(s) AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
Representative Drug(s) D0NT3V Drug Info N.A. Click to Show More [3]
2 D0A0ND Drug Info N.A. [3]
3 D0L5AE Drug Info N.A. [3]
Patent ID US9586942
Title Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
Abstract The present invention relates to aminotetraline and aminoindane derivatives of the formula (I) or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such aminotetraline and aminoindane derivatives, and the use of such aminotetraline and aminoindane derivatives for therapeutic purposes. The aminotetraline and aminoindane derivatives are GlyT1 inhibitors.
Applicant(s) AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.
Representative Drug(s) D0NT3V Drug Info N.A. Click to Show More [3]
2 D0A0ND Drug Info N.A. [3]
3 D0L5AE Drug Info N.A. [3]
References  Top
REF 1 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy. US9656955.
REF 2 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy. US9586945.
REF 3 Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy. US9586942.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.